# prochlorperazine edisylate

NDC: 67457-640
Generic name: prochlorperazine edisylate
Labeler / Manufacturer: Mylan Institutional LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20190403

FDA application: ANDA210710

## Active ingredients

- PROCHLORPERAZINE EDISYLATE: 5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67457-640"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67457-640
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=185c1647-06ea-401e-ad1d-8727d77eb827